All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Hepatitis B, Chronic-16757620

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	16757620	A194T	S	S	Hepatitis B, Chronic	S C L	View
2	16757620	C107R	S	S	Hepatitis B, Chronic	S C L	View
3	16757620	G185E	S	S	Hepatitis B, Chronic	S C L	View
4	16757620	G202R	S	S	Hepatitis B, Chronic	S C L	View
5	16757620	I152F	S	S	Hepatitis B, Chronic	S C L	View
6	16757620	I213L	S	S	Hepatitis B, Chronic	S C L	View
7	16757620	L49H	S	S	Hepatitis B, Chronic	S I C L	View
8	16757620	M133K	S	S	Hepatitis B, Chronic	S C L	View
9	16757620	P153T	S	S	Hepatitis B, Chronic	S C L	View
10	16757620	P46H	S	S	Hepatitis B, Chronic	S I C L	View
11	16757620	S45A	S	S	Hepatitis B, Chronic	S I C L	View
12	16757620	T125A	S	S	Hepatitis B, Chronic	S C L	View
13	16757620	Y161S	S	S	Hepatitis B, Chronic	S C L	View
14	16757620	I401S	P	P	Hepatitis B, Chronic	S C L	View
15	16757620	I569F	P	P	Hepatitis B, Chronic	S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.